(BUSINESS WIRE)--Biosense Webster, Inc., a Johnson & Johnson company, and a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the successful completion of the first clinical cases with the new THERMOCOOL® SMARTTOUCH™ Contact Force Sensing Catheter in the European Union, following recent CE Mark approval. The device is pending clinical investigation in the U.S. and FDA has not yet approved it for sale.
